🇹🇷 Türkçe

Koob & Volkow (2016) — Neurobiology of Addiction: A Neurocircuitry Analysis

Full citation: Koob GF, Volkow ND. “Neurobiology of addiction: a neurocircuitry analysis.” Lancet Psychiatry. 2016 Aug;3(8):760–773. doi:10.1016/S2215-0366(16)00104-8.

File: raw/neurobiology of addiction.pdf

Institutions: National Institute on Alcohol Abuse and Alcoholism (Koob); National Institute on Drug Abuse (Volkow), NIH

Summary

A comprehensive review elaborating a heuristic neurocircuitry framework for addiction as a three-stage, recurring cycle. Integrates neuropsychopharmacology, brain imaging, and animal model data. Identifies three major neurobiological circuits (basal ganglia, extended amygdala, prefrontal cortex) corresponding to three functional domains (incentive salience, negative emotional states, executive function) and maps 18 neurochemically defined mini-circuits within them.

Core thesis: addiction is a dramatic dysregulation of motivational circuits driven by (1) exaggerated incentive salience and habit formation, (2) reward deficits and stress surfeits, and (3) compromised executive function — progressively worsening across three stages.

Key Arguments and Findings

Three-Stage Cycle Framework

  • Binge/Intoxication: Dopamine and opioid peptide release in ventral striatum (basal ganglia); incentive salience; habit formation via striatal-pallidal-thalamo-cortical loops; impulsivity.
  • Withdrawal/Negative Affect: Decreased dopamine/serotonin transmission; recruitment of CRF, dynorphin, and norepinephrine stress systems in extended amygdala; anti-reward; habenula-mediated aversive signalling; compulsivity.
  • Preoccupation/Anticipation (Craving): Prefrontal cortex glutamatergic dysregulation to basal ganglia and extended amygdala; insula interoception; D2 receptor deficits in striatum; executive function impairment.

Reward System

  • Dopamine release in ventral striatum is central to drug reward across all substances.
  • Fast, steep dopamine increases activate low-affinity D1 receptors → subjective high and conditioned responding.
  • D2 receptors may limit drug reward; reduced D2 availability in striatum persists for months post-detoxification and predicts worse treatment outcomes.
  • Drug-induced phasic dopamine triggers recruitment of dorsal striatum → habit formation → compulsive responding.

Anti-Reward / Stress Systems

  • Chronic drug exposure recruits brain stress systems (CRF, dynorphin, norepinephrine) in the extended amygdala as between-system neuroadaptations.
  • CRF increases in extended amygdala during withdrawal; CRF receptor antagonists block anxiety-like withdrawal effects and excessive drug seeking in animals.
  • Îş-opioid receptor antagonists in NAc shell block compulsive drug seeking.
  • Habenula encodes aversive states; drives dopamine neuron silencing in VTA.
  • Anti-stress systems (neuropeptide Y, nociceptin, endocannabinoids) buffer brain stress; downregulated with chronic drug use.

Executive Function / Preoccupation Stage

  • Glutamatergic projection from prelimbic PFC to NAc mediates drug-induced reinstatement.
  • Cue-induced reinstatement involves PFC + basolateral amygdala + ventral subiculum → NAc circuit.
  • Stress-induced reinstatement depends on CRF and norepinephrine in extended amygdala and VTA.
  • Insula integrates interoceptive/visceral signals with motivation; insula lesions in smokers eliminate craving and relapse.
  • D2 striatal deficits → reduced PFC metabolism → impaired inhibitory control, decision making, working memory.
  • Go system (basal ganglia) drives craving; Stop system (ventromedial PFC) inhibits it — addiction biases toward Go.

Molecular Mechanisms

  • Chronic drug exposure upregulates cAMP/PKA signalling in NAc → critical neuroadaptation for addicted state.
  • CREB activation in NAc decreases reward value (dysphoric state); deactivation in central amygdala.
  • ΔFosB accumulates with repeated drug use → sustained molecular switch increasing drug sensitivity.
  • Cocaine induces histone modifications that alter pre-mRNA splicing in a combinational chromatin signature pattern.
  • AMPA receptor recruitment (especially calcium-permeable) in infralimbic PFC-to-NAc circuit underlies craving incubation.
  • mTORC1 pathway activated by drug/alcohol cues; blockade disrupts reconsolidation of cocaine and alcohol memories.
  • Adolescent alcohol use → epigenetic modifications in amygdala → increased anxiety susceptibility and alcohol intake in adulthood.

Genetics

  • Addiction heritability: 40–60%.
  • D1 receptor knockout rats won’t self-administer cocaine; ÎĽ-opioid receptor knockout mice show no opioid reward.
  • α4/α5 nicotinic receptor subunit variants → nicotine dependence vulnerability.
  • CRHR1 polymorphisms associated with binge drinking in adolescents and stress-triggered heavy drinking.
  • ADH1B and ALDH2 alleles protective against alcoholism (alcohol metabolism).
  • FAAH C385A variant → enhanced fronto-amygdala connectivity, fear extinction, reduced anxiety.

Behavioural Addictions

  • Pathological gambling, binge-eating disorder, compulsive buying, internet addiction share the three-stage cycle.
  • Similar brain mechanisms: reward deficits, stress sensitisation, D2 deficits, impaired inhibitory control.

How This Updates the Wiki

  • Introduces addiction as a new condition page with a formal neurocircuitry framework.
  • Creates three new mechanism pages: dopamine reward system, anti-reward/stress systems, executive function dysregulation.
  • Opens debate on addiction-as-brain-disease.
  • Adds cross-condition links: CRF overlap with depression (existing pages); ΔFosB overlap with depression (Nestler 2016).

Limitations Noted by Authors

  • No animal model fully emulates human addiction.
  • Craving does not consistently correlate with relapse in clinical studies.
  • Genetic studies identify only a small number of confirmed human vulnerability genes.
  • Key open questions: genetic loading of mini-circuits; how environment conveys epigenetic influences; circuit recovery with abstinence.